Tert-butyl ((5-oxopyrrolidin-2-yl)methyl)carbamate, 98%, 500mg

(E)-4-Morpholinobut-2-enoic acid hydrochloride, 98%, 1g

N-Me-Val-OMe HCl, 95.0%, 10g

4-[3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]morpholine>98.0%(GC)1g

Apósito en rollo Leukoplast®, 5 mx 25,0 mm, 3 rollos

1-Fluoro-4-(2-nitroethenyl)benzene>98.0%(GC)1g

4-Phenyl-1H-pyrrole-3-carboxylic acid, 97.0%, 5g

(5-Bromopyrazin-2-yl)methanol, 97%, 2.5g

2,3-Dichloropyridine-5-boronic acid, 95.0%, 10g

5-Bromo-6-oxo-1,6-dihydropyridine-2-carbonitrile, 95%, 5g

5-Bromo-7-chloroindolin-2-one, 96%, 500mg

Benzeneacetamide, N-[5-[[7-cyano-2-[(cyclopropylcarbonyl)amino]-6-benzothiazolyl]oxy]-2-fluorophenyl]-3-(trifluoromethyl)-, 50mg

1-(Tert-butyl) 3-ethyl (3S,4R)-4-hydroxypyrrolidine-1,3-dicarboxylate, 98%, 100mg